Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-8260
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma ; volume:4 ; number:1 ; day:9 ; month:1 ; year:2018 ; pages:1-6 ; date:12.2018
Clinical diabetes and endocrinology ; 4, Heft 1 (9.1.2018), 1-6, 12.2018
- Keyword
-
Endokrinologie
- Creator
-
Buras, Eric D.
- Contributor
-
Weatherup, Emily
Wyckoff, Jennifer
SpringerLink (Online service)
- DOI
-
10.1186/s40842-017-0053-0
- URN
-
urn:nbn:de:1111-201803011687
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Buras, Eric D.
- Weatherup, Emily
- Wyckoff, Jennifer
- SpringerLink (Online service)
Other Objects (12)
Regulation of IGF-1 bioactivity by dietary hormones, impact of glucagon and insulin-induced hypoglycemia
Nasal glucagon: A new hope for severe hypoglycemia in type 1 diabetes
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia
Glucagon
Mini-Dose Ready-to-Use Liquid Glucagon for Post-Bariatric Hypoglycemia Treatment in Experimental and Real-World Settings
Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion
Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia
Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study
Fetal and Neonatal Hypoglycemia
Clopidogrel induced autoimmune hypoglycemia
SUBCUTANEOUS
Regulation of IGF-1 bioactivity by dietary hormones, impact of glucagon and insulin-induced hypoglycemia
Nasal glucagon: A new hope for severe hypoglycemia in type 1 diabetes
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia
Glucagon
Mini-Dose Ready-to-Use Liquid Glucagon for Post-Bariatric Hypoglycemia Treatment in Experimental and Real-World Settings
Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion
Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia
Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study
Fetal and Neonatal Hypoglycemia
Clopidogrel induced autoimmune hypoglycemia
SUBCUTANEOUS
Regulation of IGF-1 bioactivity by dietary hormones, impact of glucagon and insulin-induced hypoglycemia
Nasal glucagon: A new hope for severe hypoglycemia in type 1 diabetes
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia
Glucagon
Mini-Dose Ready-to-Use Liquid Glucagon for Post-Bariatric Hypoglycemia Treatment in Experimental and Real-World Settings
Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion
Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia
Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study
Fetal and Neonatal Hypoglycemia
Clopidogrel induced autoimmune hypoglycemia